Medable Inc, the leading cloud platform for patient-centered drug development, on Tuesday, announced the first stage of its European expansion plans with a new EMEA headquarters in Dublin. The regional headquarters will serve as a hub for expanded sales, customer success and software development in Europe, enabling Medable to continue broad adoption of digital clinical trials at a global scale.
Medable’s European expansion is designed to enable greater engagement with hundreds of pharma, biotech and medical device companies across the UK, Germany, Switzerland, Spain and Benelux. Medable’s European operations will also help the company support clinical trial deployments in Europe, providing remote and site-based access for patients from anywhere.
Medable has an existing presence in Europe with roughly 60 employees and contractors currently based in the UK, Germany, Denmark and various other locations in Central and Eastern Europe.
The company intends to hire up to 50 positions in Dublin over the next three years, as part of its extensive growth across Europe in coming years. The new headquarters will serve as a hub for expanded sales, customer success and software development in Europe.
An emerging leader in the industry’s shift to decentralized clinical trials, Medable is making trials accessible for everyone and enabling effective therapies to reach patients faster. Medable’s software-as-a-service (SaaS) platform has been deployed in more than 60 countries via more than 150 decentralized and hybrid clinical trials. By minimizing the need for in-person site visits, Medable customers have achieved unprecedented results – including 3X faster enrollment, 90 percent retention rates, and 50 percent cost reductions. The company is supported by the Irish Government through IDA Ireland.
Tánaiste and Minister for Enterprise, Trade & Employment Leo Varadkar TD said, “I’m really pleased Medable has chosen Ireland for its new EMEA headquarters, creating up to 50 new jobs in Dublin over the next three years.”